CytomX Therapeutics Inc. (CTMX) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-11-07
11:13 am
Purchase
2025-10-3113GCytomX Therapeutics, Inc.
CTMX
FMR LLC20,519,967
12.400%
5,123,767increase
(+33.28%)
Filing
History
2025-11-05
11:30 am
Purchase
2025-09-3013GCytomX Therapeutics, Inc.
CTMX
FMR LLC15,396,200
9.300%
6,157,332increase
(+66.65%)
Filing
History
2025-08-21
4:00 pm
Purchase
2025-08-1413GCytomX Therapeutics, Inc.
CTMX
Perceptive Advisors LLC9,680,185
5.900%
7,103,142increase
(+275.63%)
Filing
History
2025-08-14
6:07 pm
Purchase
2025-06-3013GCytomX Therapeutics, Inc.
CTMX
ORBIMED ADVISORS LLC8,461,500
5.400%
8,461,500increase
(New Position)
Filing
History
2025-08-14
5:30 pm
Sale
2025-06-3013GCytomX Therapeutics, Inc.
CTMX
Point72 Asset Management, L.P.8,084,623
5.100%
-5,009,777decrease
(-38.26%)
Filing
History
2025-08-14
4:15 pm
Purchase
2025-06-3013GCytomX Therapeutics, Inc.
CTMX
TANG CAPITAL MANAGEMENT, LLC11,065,662
7.000%
4,347,837increase
(+64.72%)
Filing
History
2025-08-06
11:56 am
Purchase
2025-06-3013GCytomX Therapeutics, Inc.
CTMX
FMR LLC9,238,868
5.900%
7,100,090increase
(+331.97%)
Filing
History
2025-07-29
11:22 am
Purchase
2025-06-3013GCytomX Therapeutics, Inc.
CTMX
VANGUARD GROUP INC9,379,794
5.950%
4,476,851increase
(+91.31%)
Filing
History
2025-07-09
7:55 pm
Sale
2025-07-0313GCytomX Therapeutics, Inc.
CTMX
BIOTECHNOLOGY VALUE FUND L P5,769,231
3.500%
-5,769,231decrease
(-50.00%)
Filing
History
2025-07-09
7:53 pm
Purchase
2025-06-3013GCytomX Therapeutics, Inc.
CTMX
BIOTECHNOLOGY VALUE FUND L P11,538,462
6.800%
3,448,667increase
(+42.63%)
Filing
History
2025-05-20
9:02 pm
Purchase
2025-05-1313GCytomX Therapeutics, Inc.
CTMX
Seven Fleet Partners LP377,161
0.200%
377,161increase
(New Position)
Filing
History
2025-05-20
9:00 pm
Purchase
2025-05-1313GCytomX Therapeutics, Inc.
CTMX
Longitude Capital Partners V, LLC11,538,461
7.300%
11,538,461increase
(New Position)
Filing
History
2025-05-20
4:25 pm
Purchase
2025-05-1313GCytomX Therapeutics, Inc.
CTMX
Venrock Healthcare Capital Partners III, L.P.12,992,500
8.200%
12,992,500increase
(New Position)
Filing
History
2025-05-15
4:15 pm
Sale
2025-03-3113GCytomX Therapeutics, Inc.
CTMX
TANG CAPITAL MANAGEMENT, LLC6,717,825
8.400%
-1,093,935decrease
(-14.00%)
Filing
History
2025-05-14
5:14 pm
Purchase
2025-05-1213GCytomX Therapeutics, Inc.
CTMX
Point72 Asset Management, L.P.13,094,400
8.300%
13,094,400increase
(New Position)
Filing
History
2025-02-14
11:34 am
Sale
2024-12-3113GCytomX Therapeutics, Inc.
CTMX
JANUS HENDERSON GROUP PLC
JHG
0
0.000%
-4,809,518decrease
(Position Closed)
Filing
History
2024-11-14
4:26 pm
Purchase
2024-09-3013GCytomX Therapeutics, Inc.
CTMX
BIOTECHNOLOGY VALUE FUND L P8,089,795
9.990%
1,386,906increase
(+20.69%)
Filing
History
2024-11-14
4:00 pm
Purchase
2024-09-3013GCytomX Therapeutics, Inc.
CTMX
TANG CAPITAL MANAGEMENT, LLC7,811,760
9.990%
7,811,760increase
(New Position)
Filing
History
2024-11-14
3:03 pm
Sale
2024-09-3013GCytomX Therapeutics, Inc.
CTMX
Cormorant Asset Management, LP0
0.000%
-5,750,000decrease
(Position Closed)
Filing
History
2024-11-14
12:28 pm
Purchase
2024-09-3013GCytomX Therapeutics, Inc.
CTMX
JANUS HENDERSON GROUP PLC
JHG
4,809,518
6.200%
651,408increase
(+15.67%)
Filing
History
Goto 0, 1, 2, Next